BYETTA s.c.injection 10mcg Pen 300 (バイエッタ皮下注10μgペン300)

Land: Japan

Tungumál: enska

Heimild: すりの適正使用協議会 RAD-AR Council, Japan

Kauptu það núna

Virkt innihaldsefni:

Exenatide

Fáanlegur frá:

AstraZeneca K.K

INN (Alþjóðlegt nafn):

Exenatide

Lyfjaform:

clear and colorless injectable preparation

Upplýsingar fylgiseðill

                                Drug Information Sheet("Kusuri-no-Shiori")
Self-injection
Published: 04/2013
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
BYETTA S.C.INJECTION 10MCG PEN 300
ACTIVE INGREDIENT:
Exenatide
DOSAGE FORM:
clear and colorless injectable preparation
IMPRINT OR PRINT ON WRAPPING:
EFFECTS OF THIS MEDICINE
This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist.
This medicine improves
glycemic control through the actions of enhancing glucose-dependent
insulin secretion and
suppressing glucagon secretion via GLP-1 receptor.
This medicine is commonly used for the treatment of type 2 diabetes
mellitus.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you have diabetic ketoacidosis, diabetic coma, precoma, infections
or renal disease.
If you are type 1 diabetes.
If you are on dialysis.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other prescription medicines.)
DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE)
・
Your dosing schedule prescribed by your doctor is((         
           
to be written by a healthcare
professional
))
・In general, for adults, inject subcutaneously 5mcg (active
ingredient) per dose twice daily
within 60 minutes before your morning and evening meals. Although the
dosage is
increased up to 10mcg per dose based on your clinical status at least
one month af
                                
                                Lestu allt skjalið
                                
                            

Leitaðu viðvaranir sem tengjast þessari vöru